Clinical Trial

Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment

Recruiting

Record status

This record was last updated September 30, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a study on the efficacy and safety of fospropofol disodium for injection in painless endoscopic diagnosis and treatment, project No.2024-YCRF-M1021, which will take more than 2 years to complete. This is a multicenter, randomized, double-blind, controlled clinical study. Using a computer-generated randomized number table, the patients were divided into two groups: the group L (fospropofol disodium group) and the group B (propofol group). After determining the group of enrolled patients, the drug was administered by two fixed anesthesiologists By participating in this study, it is possible to make your anesthesia induction stable, stable intraoperative circulation, awake and safe and comfortable, to reduce the incidence of intraoperative hypoxemia, intraoperative awareness, cardiovascular and cerebrovascular malignant events (malignant arrhythmia, cardiac arrest), which is conducive to your rapid postoperative recovery and reduce hospitalization costs.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-12-11.

Status change: Not Yet Recruiting → Recruiting 2025-09-25

Trial Details

NCT Number	NCT06732427
Lead Sponsor	Affiliated Hospital of Nantong University Collaborators: Rugao People's Hospital, Qidong People's Hospital, Hai 'an People's Hospital, Rudong County Hospital of Traditional Chinese Medicine
Conditions	Efficacy and Safety
Enrollment	426 participants
Start Date	2025-08-12
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-09-30